Description
Details
PureStem® ES-101 Progenitor expresses transthyretin (TTR), a marker of Blood Brain Barrier cells and choroid plexus making this progenitor valuable for research into diseases related to Cerebral Spinal Fluid or Alzheimer’s disease where defective choroid plexus function has been hypothesized. PureStem Progenitor ES-101 was derived from the parental hES cell line MA03 as described (West, M.D. et al, 2008).
Propagation Potential
PureStem Progenitor ES-101, is sold at passage 12 (the original clonal isolate confluent in a 1.9 cm2 well was P1), which corresponds to approximately 15 doublings since the first 1.9 cm2 well and approximately 33 doublings since its original clonal plating.
Propagation Potential
PureStem Progenitor ES-101, is sold at passage 12 (the original clonal isolate confluent in a 1.9 cm2 well was P1), which corresponds to approximately 15 doublings since the first 1.9 cm2 well and approximately 33 doublings since its original clonal plating.
Details
Details
| Quality Control | This line is negative for HIV (1, 2), HBV, HCV, bacteria, mycoplasma, and fungal contamination. Certificates of analysis are available on request. |
|---|---|
| Technical Documents | ES-101 Technical Data Sheet |
| References | West MD, et al. (2008) The ACTCellerate initiative: large-scale combinatorial cloning of novel human embryonic stem cell derivatives. Regen Med. 3(3):287-308. PMID: 18462054 |